Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA

The U.S. Food and Drug Administration (FDA) embarked on a data and IT infrastructure modernization program before COVID-19 hit. Although the pandemic shifted priorities, modernization remains an urgent and growing need. Data and infrastructure modernization, in fact, is critical to maintaining and expanding the Agency’s status as the world’s regulatory gold standard. Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues.
Read more...

;